Suppr超能文献

从马尼拉医蛭中分离凝血酶抑制剂。

Isolation of thrombin inhibitor from the leech Hirudinaria manillensis.

作者信息

Electricwala A, Sawyer R T, Jones C P, Atkinson T

机构信息

Division of Biotechnology, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, UK.

出版信息

Blood Coagul Fibrinolysis. 1991 Feb;2(1):83-9. doi: 10.1097/00001721-199102000-00013.

Abstract

The leech Hirudinaria manillensis belongs to the same family as the medicinal leech Hirudo medicinalis, which has been widely used for the study of hirudin, a specific thrombin inhibitor. A similar inhibitor has now been isolated from the heads of the Hirudinaria leech by acetone/acid extraction and further purified to near homogeneity by ion exchange chromatography followed by affinity chromatography on thrombin-agarose and reverse phase HPLC. The purified material was recovered at about 10-15% yield and had a specific activity of about 12,000-14,000 ATU/mg, similar to other hirudin variants. The inhibitor was shown to be homogenous by sodium dodecyl sulphate/polyacrylamide gel electrophoresis in the presence of 8 M urea with an apparent molecular mass of about 7000 daltons under reducing conditions. Comparison of the anticoagulant effect on human plasma by partial thromboplastin time assay have shown that the inhibitor from Hirudinaria has similar potency as hirudin variant 1 at equivalent dosage. However, it does not cross-react with monoclonal antibodies towards recombinant hirudin variant 1. Comparison of the N-terminal amino acid sequence up to residue 25 also indicates differences at positions 2, 13, 17 and 24 between the two thrombin inhibitors. These findings indicate that the primary anticoagulant present in the leech Hirudinaria is a potent thrombin inhibitor (Bufrudin) with biological activity similar to hirudin, but differs in its structural and immunological properties.

摘要

马尼拉医蛭(Hirudinaria manillensis)与药用医蛭(Hirudo medicinalis)同属一个科,药用医蛭已被广泛用于水蛭素(一种特异性凝血酶抑制剂)的研究。现在,通过丙酮/酸提取法从马尼拉医蛭的头部分离出了一种类似的抑制剂,并通过离子交换色谱法进一步纯化至接近均一,随后在凝血酶-琼脂糖上进行亲和色谱法以及反相高效液相色谱法。纯化后的物质回收率约为10%-15%,比活性约为12,000-14,000 ATU/mg,与其他水蛭素变体相似。在8 M尿素存在的情况下,通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳显示该抑制剂在还原条件下具有均一性,表观分子量约为7000道尔顿。通过部分凝血活酶时间测定法比较其对人血浆的抗凝作用表明,在等效剂量下,来自马尼拉医蛭的抑制剂与水蛭素变体1具有相似的效力。然而,它与针对重组水蛭素变体1的单克隆抗体不发生交叉反应。对直至第25个残基的N端氨基酸序列进行比较也表明,这两种凝血酶抑制剂在第2、13、17和24位存在差异。这些发现表明,马尼拉医蛭中存在的主要抗凝剂是一种强效凝血酶抑制剂(布氏水蛭素),其生物活性与水蛭素相似,但其结构和免疫特性不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验